116
Participants
Start Date
October 10, 2005
Primary Completion Date
September 30, 2006
Study Completion Date
September 30, 2006
Botulinum toxin type A
500 units
Placebo
500 units
Beth Israel Medical Center, New York
USC School of Medicine, Los Angeles
Scientific Research Institute of Neurology, RAMS, Moscow
"Clinic Cecil Plus", Moscow
Municipal Multi-Speciality Hospital #2, Saint Petersburg
St Petersburg Pavlov State Medical University, Saint Petersburg
St. Joseph's Hospital and Medical Center, Phoenix
Parkinson's and Movement Disorder Institute, Fountain Valley
University of Florida, Gainesville
University of Miami, Miami
Emory University, Atlanta
Rush University Medical Center, Chicago
University of Iowa, Iowa City
University of Maryland Medical Center, Baltimore
Wayne State University Medical Center, Southfield
Albany Medical Center, Albany
Columbia University, New York
Wake Forest University, Winston-Salem
Allegeheny General, Pittsburgh
University of Texas Southwest, Dallas
Baylor College of Medicine, Houston
Swedish Neuroscience, Seattle
Lead Sponsor
Ipsen
INDUSTRY